Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Cell MedX Corp. (OTC: CMXC).

Full DD Report for CMXC

Recent News from (OTC: CMXC)

Cell MedX Corp. Appoints Dr. George Adams as Director
Carson City, Nevada--(Newsfile Corp. - March 26, 2018) - Cell MedX Corp. (OTCQB: CMXC) (9CX: MUN), ("Cell MedX" or the "Company"), an early-stage biotech company focusing on the discovery, development and commercialization of products that promote general wellness, is pleased to announce that ...
Source: Newsfile
Date: March, 26 2018 08:00
Cell MedX Corp. Arranges a Non-Brokered Private Placement Financing
Carson City, Nevada--(Newsfile Corp. - March 19, 2018) - Cell MedX Corp. (OTCQB: CMXC) (9CX: MUN), ("Cell MedX" or the "Company"), a development stage company focused on the commercialization of therapeutic devices for patients living with diseases such as diabetes has arranged a non-brokere...
Source: Newsfile
Date: March, 19 2018 08:00
December 5, 2017; Cell MedX Corp. Appoints Dr. Terrance Owen as CEO and Director
December 5, 2017; Cell MedX Corp. Appoints Dr. Terrance Owen as CEO and Director
Source: OTC Markets
Date: January, 31 2018 00:00
Cell MedX Corp. provides additional information on its observational clinical trial with diabetes and related conditions
Carson City, Nevada--(Newsfile Corp. - January 30, 2018) - Cell MedX Corp. (OTCQB: CMXC) (9CX: MUN), ("Cell MedX" or the "Company"), is an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that prom...
Source: Newsfile
Date: January, 30 2018 08:00
Cell MedX Corp. Assigned Legal Entity Identifier Number by Deutsche Börse Group
Carson City, Nevada--(Newsfile Corp. - January 29, 2018) - Cell MedX Corp. (OTCQB: CMXC) (9CX:MUN), ("Cell MedX" or the "Company"), announces that it has been assigned a Legal Entity Identifier number 967600RJ7LKTH79OWE67. About the Legal Entity Identifier Number ("LEI") The European Union h...
Source: Newsfile
Date: January, 29 2018 08:00
Cell MedX Corp. Assigned Legal Entity Identifier Number
Cell MedX Corp. Assigned Legal Entity Identifier Number
Source: OTC Markets
Date: January, 29 2018 00:00
Cell MedX Corp. completes its first observational clinical trial and observes positive results with diabetes and related conditions
Carson City, Nevada--(Newsfile Corp. - January 24, 2018) - Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general we...
Source: Newsfile
Date: January, 24 2018 08:00
Cell MedX Corp. completes its first observational clinical trial and observes
Cell MedX Corp. completes its first observational clinical trial and observes
Source: OTC Markets
Date: January, 24 2018 00:00
Cell MedX Corp. Appoints Dr. Terrance Owen as CEO and Director
Carson City, Nevada--(Newsfile Corp. - December 5, 2017) - Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general we...
Source: Newsfile
Date: December, 05 2017 08:00
Cell MedX Corp. Closes the First Tranche of Its Non-Brokered Private Placement Financing, Converts Debt
Carson City, Nevada--(Newsfile Corp. - October 19, 2017) - Cell Med X Corp. (OTC QB : CMXC) ("Cell MedX" or the "Company"), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote...
Source: Newsfile
Date: October, 19 2017 08:02

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-210.14990.14990.14990.1499300
2018-04-200.14990.14990.14990.1499300
2018-04-190.14990.14990.14990.1499138
2018-04-18N/A0.15N/AN/A0
2018-04-17N/A0.15N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-04-165001,50033.3333Cover
2018-04-061,7501,750100.0000Short
2018-03-295,7005,700100.0000Short
2018-03-234,4879,38747.8001Short
2018-03-1631581538.6503Short

* Short Mode

Short Analysis provided by Squeeze Report.


About Cell MedX Corp. (OTC: CMXC)

Logo for Cell MedX Corp. (OTC: CMXC)

lt p gt Cell MedX Corp. is an early development stage bio tech company focused on the discovery, development and commercialization of therapeutic and non therapeutic products that promote general wellness and alleviate complications associated with medical conditions including, but not limited to, diabetes, Parkinson s disease, high blood pressure. lt /p gt

 

Contact Information

 

 

Current Management

  • Frank E. McEnulty / CEO, President, Treasurer
  • Yanika Silina / CFO, Treasurer, Corporate Secretary
  • Bradley S. Hargreaves / Vice President, Other
  • Dr. Sanderson M.D. / Chief Med. Officer
  • Frank E. McEnulty /
  • Yanika Silina /

Current Share Structure

  • Market Cap: $8,156,717 - 03/15/2018
  • Authorized: 300,000,000 - 06/26/2017
  • Issue and Outstanding: 44,042,749 - 01/16/2018
  • Float: 30,995,607 - 10/13/2017

 


Recent Filings from (OTC: CMXC)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 26 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: January, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 05 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: October, 17 2017
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: August, 29 2017
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: May, 08 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 14 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 28 2017
Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock
Filing Type: 144Filing Source: edgar
Filing Date: February, 03 2017

 

 


Daily Technical Chart for (OTC: CMXC)

Daily Technical Chart for (OTC: CMXC)


Stay tuned for daily updates and more on (OTC: CMXC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CMXC)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CMXC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of CMXC and does not buy, sell, or trade any shares of CMXC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us